Vanderbilt Eye Institute

Retinal neuron survival in glaucoma

Understanding how the protein TRPV1 helps neurons survive after glaucoma-related stressors could lead to new therapeutic strategies for glaucoma and other neurodegenerative conditions.

Project PAVE’s impact on children’s vision easy to see

It’s been 20 years since Project PAVE, a Tennessee program providing low-vision evaluations for children, was launched.

Novel therapy eases stress of retinoblastoma treatment

Conventional therapy for patients diagnosed with retinoblastoma, the most common ocular cancer in children, includes systemic chemotherapy, external beam radiation and/or surgical removal of the eye. Doctors at Vanderbilt University Medical Center are on track to radically change the way the disease is treated using an emerging therapeutic approach called intra-arterial chemotherapy, or IA chemo.

Biomarker for diabetic eye disease

A person’s mitochondrial gene “signature” could predict risk for diabetic retinopathy and guide early intervention strategies.

Keeping an eye on blast trauma

Understanding the cellular and molecular responses of the eye to blast injury could guide new treatment development.

Award highlights Wayman’s resident education efforts

Laura Wayman, M.D., associate professor of Ophthalmology and Visual Sciences, has been awarded the 2014 Straatsma Award for Excellence in Resident Education.

1 5 6 7 8 9 10